The sputum transcriptome better predicts COPD exacerbations after the withdrawal of inhaled corticosteroids than sputum eosinophils

INTRODUCTION: Continuing inhaled corticosteroid (ICS) use does not benefit all patients with COPD, yet it is difficult to determine which patients may safely sustain ICS withdrawal. Although eosinophil levels can facilitate this decision, better biomarkers could improve personalised treatment decisi...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:ERJ Open Res
Asıl Yazarlar: Ditz, Benedikt, Sarma, Aartik, Kerstjens, Huib A.M., Liesker, Jeroen J.W., Bathoorn, Erik, Vonk, Judith M., Bernal, Victor, Horvatovich, Peter, Guryev, Victor, Caldera, Saharai, Langelier, Chaz, Faiz, Alen, Christenson, Stephanie A., van den Berge, Maarten
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: European Respiratory Society 2021
Konular:
Original Research Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8255541/
https://ncbi.nlm.nih.gov/pubmed/34235210
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00097-2021
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller